XML 26 R14.htm IDEA: XBRL DOCUMENT
v3.21.2

Notes Payable | 6 Months Ended
--- | ---
Jun. 30, 2021
Notes Payable |
Notes Payable | Note 6 – Notes Payable As of June 30, 2021 and December 31, 2020, notes payable consisted of the following: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | June 30, 2021 |  | December 31, 2020
​ | ​ | ​ | ​ | Non- | ​ | ​ | ​ | ​ | ​ | Non- | ​ | ​
​ | ​ | Current | ​ | Current | ​ | ​ | ​ | Current | ​ | Current | ​ | ​
​ |  | Portion |  | Portion |  | Total |  | Portion |  | Portion |  | Total
BankDirect Capital Finance loan | ​ | $ | 393,797 | ​ | $ | — | ​ | $ | 393,797 | ​ | $ | — | ​ | $ | — | ​ | $ | —
Paycheck Protection Program loan | ​ | ​ | 463,353 | ​ | ​ | — | ​ | ​ | 463,353 | ​ | ​ | 97,539 | ​ | ​ | 365,814 | ​ | ​ | 463,353
Silicon Valley Bank loan | ​ | ​ | 102,613 | ​ | ​ | 6,994,893 | ​ | ​ | 7,097,506 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | —
Total | ​ | $ | 959,763 | ​ | $ | 6,994,893 | ​ | $ | 7,954,656 | ​ | $ | 97,539 | ​ | $ | 365,814 | ​ | $ | 463,353
​ BankDirect Capital Finance Loan On February 24, 2021, the Company issued a note payable for the purchase of a directors and officers liability insurance policy. The note payable is payable in nine monthly payments consisting of principal and interest amounting to $79,343 for an aggregate principal amount of $705,360. The note accrues interest at a rate of 2.96% per year and matures on November 24, 2021. Paycheck Protection Program Loan On May 8, 2020, the Company received cash proceeds of $463,353 pursuant to a loan provided in connection with the Paycheck Protection Program under the CARES Act (the “PPP Loan”). The PPP Loan provides for monthly installment payments of $19,508 beginning in August 2021 with the remaining balance due on May 3, 2022, the maturity date. The PPP Loan bears interest at a fixed rate of 1.00% per annum. Under the terms of the CARES Act, as amended by the Paycheck Protection Program Flexibility Act of 2020, the Company is eligible to apply for and receive forgiveness for all or a portion of its PPP Loan. The Company applied for loan forgiveness on the PPP Loan in March 2021. Such forgiveness will be determined, subject to limitations, based on the use of the loan proceeds for certain permissible purposes as set forth in the PPP Loan, including, but not limited to, payroll costs and mortgage interest, rent or utility costs (collectively, “Qualifying Expenses”) incurred during the 24 weeks subsequent to funding, and on the maintenance of employee and compensation levels following the funding of the PPP Loan. The Company has used the proceeds of its PPP Loan for Qualifying Expenses. However, no assurance is provided that the Company will be able to obtain forgiveness of its PPP Loan in whole or in part. Any amounts that are not forgiven incur interest at 1.0% per annum and monthly repayments of principal and interest are deferred until six months after the Small Business Administration makes a determination on forgiveness. While the PPP Loan currently has a two-year maturity, the amended law permits the borrower to request a five-year maturity from its lender. During the three months ended June 30, 2021 and 2020, the Company recorded interest expense of $4,481 and $4,333, respectively. During the six months ended June 30, 2021 and 2020, the Company recorded interest expense of $6,963 and $6,032, respectively. Silicon Valley Bank Loan On May 7, 2021 (the “Effective Date”), the Company entered into a Loan and Security Agreement (the “Loan”) with Silicon Valley Bank (the “Lender”, or “SVB”) for an aggregate principal amount of up to $25.0 million. The Loan bears interest at an annual rate equal to the greater of (a) the sum of 1.25% plus the prime rate as reported in The Wall Street Journal and (b) 5.00%. The Loan is secured by all of the Company’s tangible assets. The Loan matures on May 1, 2025. The Loan requires monthly interest-only payments until June 1, 2022. The interest-only period can be extended to June 1, 2023, upon the occurrence of a milestone event. Upon the end of the interest-only period, the Company will make regular monthly amortizing payments of principal and interest through the maturity date. The Loan indicates a prepayment fee of 1.0% to 3.0%, as follows: i) prepayment fee of 3.0% of the principal balance made on or prior to the first anniversary of the Effective Date; ii) prepayment fee of 2.0% of the principal balance made on or prior to the second anniversary of the Effective Date; or iii) prepayment fee of 1.0% of the principal balance made on or prior to the third anniversary of the Effective Date. The Loan also provides for a final payment. The final payment is in addition to and not a substitution for the regular monthly payments of principal plus accrued interest due on the earliest to occur of the loan maturity date, the repayment of the loan in full or the termination of the Loan Agreement, in an amount equal to the original aggregate principal amount of the multiplied by 5.0%. The initial tranche of the Loan, in the amount of $7.5 million was received by the Company on May 7, 2021. In connection with the Loan, the Company issued to the Lender warrants to purchase 91,884 shares of common stock at an exercise price per share equal to $4.76. The warrants are exercisable for a period of ten years from the date of issuance. At the Company’s option, Eyenovia has the ability to draw down the remaining $17.5 million in gross proceeds in two tranches over the next two years based upon the achievement of several milestones in accordance with the terms of the Loan. During the period ended June 30, 2021, the Company recorded interest expense relating to the Loan of $54,516. The following are the scheduled future annual maturities, subject to an extension of the interest-only period: ​
​ | ​ | ​ | ​
Remainder of 2021 |  | $ | —
2022 | ​ | ​ | 1,458,333
2023 | ​ | ​ | 2,500,000
2024 | ​ | ​ | 2,500,000
2025 | ​ | ​ | 1,041,667
​ | ​ | $ | 7,500,000
​ The Company determined that the warrants should be equity-classified and that the relative fair value was $354,539, by using the Black-Scholes option pricing methodology using the following assumptions: stock price of $4.76; expected term of 10.0 years; volatility of 89.0% and a risk-free interest rate of 1.60%. The Company incurred $66,618 of debt issuance costs, of which $63,469 was allocated to the debt and $3,149 was allocated to the warrants. The relative fair value of the warrants and the issuance costs allocated to the debt were recorded as debt discount and are being amortized over the four-year term of the note. See the table below for additional details. ​
​ | ​ | ​ | ​
​ |  | June 30, 2021
Gross loan proceeds | ​ | $ | 7,500,000
Debt discount: | ​ |  | ​
Relative fair value of warrants | ​ |  | (354,539)
Relative fair value of issuance costs | ​ |  | (63,469)
Amortization of debt discount | ​ |  | 15,514
​ | ​ |  | 7,097,506
Note payable - current portion | ​ |  | 102,613
Note payable - non-current portion | ​ | $ | 6,994,893
​

X
- Definition The entire disclosure of notes payable. + References No definition available. + Details
Name: | eyen_NotesPayableDisclosureTextBlock
Namespace Prefix: | eyen_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_NotesPayableAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration